Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection

K-Number: K221339 · 2022-06-09

Decision Date2022-06-09
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection is a medical device manufactured by Contego Medical, Inc.. It received FDA 510(k) clearance on 2022-06-09 under approval number K221339. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection?

Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection is a medical device that received FDA 510(k) clearance on 2022-06-09. It is manufactured by Contego Medical, Inc.. The 510(k) number is K221339.

When was Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection approved by the FDA?

Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection received FDA 510(k) clearance on 2022-06-09, under approval number K221339.

What company makes Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection?

Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection is manufactured by Contego Medical, Inc..

What is the FDA product code for Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection?

The FDA product code for Paladin Carotid Post-Dilation Balloon System with Integrated Embolic Protection is LIT.

Related Clinical Trials

Related PubMed Literature

Other Devices by Contego Medical, Inc.

Related Devices (Code: LIT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.